Short answer · Medically reviewed summary · Last updated: 2026-05-08
Liver cancer, specifically primary liver cancer like hepatocellular carcinoma (HCC), is a globally significant health concern with an estimated incidence of over 900,000 new cases annually. While not classified as a rare disease globally, certain subtypes or specific patient populations may be considered rare, and prevalence varies significantly based on regional risk factors like viral hepatitis and metabolic disease. What is the global prevalence and incidence of liver cancer? According to the World Health Organization’s GLOBOCAN database, primary liver cancer is the sixth most frequently diagnosed cancer worldwide.
What is the prevalence of Liver Cancer?
Prevalence of Liver Cancer: how many people are affected worldwide, differences by sex and region, with sources.
Liver cancer, specifically primary liver cancer like hepatocellular carcinoma (HCC), is a globally significant health concern with an estimated incidence of over 900,000 new cases annually. While not classified as a rare disease globally, certain subtypes or specific patient populations may be considered rare, and prevalence varies significantly based on regional risk factors like viral hepatitis and metabolic disease.
What is the global prevalence and incidence of liver cancer?
According to the World Health Organization’s GLOBOCAN database, primary liver cancer is the sixth most frequently diagnosed cancer worldwide. The incidence of liver cancer is closely tied to the prevalence of underlying risk factors, such as Hepatitis B and C infections, non-alcoholic fatty liver disease (NAFLD), and alcohol consumption. It is estimated that approximately 830,000 deaths occur annually due to liver cancer, reflecting its high mortality rate relative to its incidence.
How does liver cancer affect different demographics?
The distribution of liver cancer is not uniform; it exhibits clear patterns based on sex, age, and geography:
- Gender: Liver cancer is significantly more common in males than females, with a global male-to-female ratio of approximately 2:1 to 3:1.
- Age: While liver cancer can occur at any age, the incidence typically peaks in adults between the ages of 50 and 70.
- Geography: The highest burden of liver cancer is observed in East and Southeast Asia and sub-Saharan Africa, largely due to endemic Hepatitis B.
What challenges exist in tracking liver cancer data?
Accurate prevalence data for liver cancer can be difficult to ascertain due to underdiagnosis in regions with limited screening infrastructure. Furthermore, as a community platform, DiseaseMaps.org currently connects 11 people living with liver cancer, providing a vital, real-world perspective on the patient journey that clinical statistics alone cannot capture. This community data complements global registries by highlighting the lived experience of those navigating this complex diagnosis.
Next steps
- Consult a hepatologist or oncologist to discuss personalized screening if you have known risk factors.
- Join the DiseaseMaps.org community to connect with others sharing their experience with liver cancer.
- Inquire with your healthcare provider about clinical trials investigating new therapeutic interventions.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
References
- World Health Organization (WHO) / IARC GLOBOCAN Database
- National Cancer Institute (NCI) - Surveillance, Epidemiology, and End Results (SEER) Program
- American Cancer Society - Cancer Facts & Figures
- NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
